CA2120603A1 - Compositions opthalmiques topiques comportant des 4-[(groupe amino substitueen 3)-2-hydroxypropoxy]-1,2,5-thiadiazoles et methodes pour leur utilisation - Google Patents

Compositions opthalmiques topiques comportant des 4-[(groupe amino substitueen 3)-2-hydroxypropoxy]-1,2,5-thiadiazoles et methodes pour leur utilisation

Info

Publication number
CA2120603A1
CA2120603A1 CA002120603A CA2120603A CA2120603A1 CA 2120603 A1 CA2120603 A1 CA 2120603A1 CA 002120603 A CA002120603 A CA 002120603A CA 2120603 A CA2120603 A CA 2120603A CA 2120603 A1 CA2120603 A1 CA 2120603A1
Authority
CA
Canada
Prior art keywords
composition
thiadiazole
ethyl
phenyl
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002120603A
Other languages
English (en)
Inventor
Louis Desantis Jr.
Robert J. Adamski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2120603A1 publication Critical patent/CA2120603A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
CA002120603A 1991-10-11 1992-10-09 Compositions opthalmiques topiques comportant des 4-[(groupe amino substitueen 3)-2-hydroxypropoxy]-1,2,5-thiadiazoles et methodes pour leur utilisation Abandoned CA2120603A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77654491A 1991-10-11 1991-10-11
US776,544 1991-10-11

Publications (1)

Publication Number Publication Date
CA2120603A1 true CA2120603A1 (fr) 1993-04-15

Family

ID=25107688

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002120603A Abandoned CA2120603A1 (fr) 1991-10-11 1992-10-09 Compositions opthalmiques topiques comportant des 4-[(groupe amino substitueen 3)-2-hydroxypropoxy]-1,2,5-thiadiazoles et methodes pour leur utilisation

Country Status (5)

Country Link
EP (1) EP0606393A1 (fr)
JP (1) JPH06511242A (fr)
AU (1) AU660735B2 (fr)
CA (1) CA2120603A1 (fr)
WO (1) WO1993006827A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1253709A (en) * 1968-05-22 1971-11-17 Frosst & Co Charles E Thiadiazole derivatives
US3655663A (en) * 1969-04-21 1972-04-11 Burton K Wasson 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
US4508725A (en) * 1982-12-22 1985-04-02 American Hospital Supply Corporation Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy

Also Published As

Publication number Publication date
AU660735B2 (en) 1995-07-06
JPH06511242A (ja) 1994-12-15
WO1993006827A1 (fr) 1993-04-15
AU2869692A (en) 1993-05-03
EP0606393A1 (fr) 1994-07-20

Similar Documents

Publication Publication Date Title
US5124154A (en) Aminosteroids for ophthalmic use
CA2013167A1 (fr) Derives d'isoquinoline pour le traitement du glaucome ou de l'hypertension oculaire
US5209926A (en) Aminosteroids for ophthalmic use
US12290511B2 (en) Pharmaceutical preparation containing pyridyl aminoacetic acid compound
IE904069A1 (en) Compositions and their use in lowering intraocular pressure
CA1139669A (fr) Composes pour traiter le glaucome
AU704938B2 (en) Combination therapy for treating glaucoma
US6069139A (en) Method and composition for prophulaxis and treatment of retinal diseases
EP0664705B1 (fr) Compositions de derives de l'ergoline pour le traitement du glaucome
US5288759A (en) Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis
EP0509752A2 (fr) Compositions ophtalmiques contenant des combinaisons d'un inhibiteur d'anhydrase carbonique et d'un antagoniste bêta-adrénergique
JPWO1997040834A1 (ja) ジヒドロピリジン化合物を含有する眼組織末梢循環改善剤
JPH10324640A (ja) 炭酸脱水酵素阻害剤およびβ遮断剤を含有する局所用抗緑内障組成物
CA2120603A1 (fr) Compositions opthalmiques topiques comportant des 4-[(groupe amino substitueen 3)-2-hydroxypropoxy]-1,2,5-thiadiazoles et methodes pour leur utilisation
CA2306371C (fr) Utilisation de la flunarizine pour le traitement topique du glaucome
KR980008226A (ko) 시각기능장애의 예방 및 치료제
JP4300347B2 (ja) ブナゾシンとプロスタグランジン類からなる緑内障治療剤
US5320839A (en) Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
CZ282168B6 (cs) Oční místní prostředek obsahující hemihydrát (S)-timololu, jeho použití a způsob jeho přípravy
KR20050104387A (ko) 안압 저하제
US4322425A (en) Compositions for treating glaucoma
SE451070B (sv) Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom
AU716577B2 (en) Use of polyamine antagonists for the treatment of glaucoma
JPH02295925A (ja) 局所的耐性が改善された局所眼科用医薬組成物
EP0375319A3 (fr) Utilisation des inhibiteurs de l'enzyme convertissant l'angiotensine dans le traitement du glaucome

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead